β-catenin knockdown inhibits pituitary adenoma cell proliferation and invasion via interfering with AKT and gelatinases expression

International Journal of Oncology

Volumn 46, Issue 4, 2015, Pages 1643-1650

  Zhao, Chengcheng ^a,b   Zhang, Meng ^b   Liu, Wenlan ^b   Wang, Chuanfang ^b   Zhang, Qiusheng ^b   Li, Weiping ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Invasion; Pituitary adenoma; Proliferation; shRNA; catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; GELATINASE A; GELATINASE B; GROWTH HORMONE; MESSENGER RNA; PROTEIN KINASE B; STAT3 PROTEIN; CTNNB1 PROTEIN, MOUSE; GELATINASE;

ADENOMA CELL LINE; ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL DENSITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE SILENCING; GENETIC TRANSFECTION; HYPOPHYSIS ADENOMA; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOMA; ANIMAL; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HYPOPHYSIS TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ADENOMA; ANIMALS; BETA CATENIN; CELL MOVEMENT; CELL PROLIFERATION; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; MICE; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84923088315     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2862     Document Type: Article

References (38)

1. VANDEVA S, JAFFRAIN-REA ML, DALY AF, TICHOMIROWA M, ZACHARIEVA S and BECKERS A: The genetics of pituitary adenomas. best Pract Res Clin Endocrinol Metab 24: 461-476, 2010.
2. MELMED S: Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7: 257-266, 2011.
3. ASA SL and EZZAT S: The pathogenesis of pituitary tumors. Annu Rev Pathol 4: 97-126, 2009.
4. DOUGLAS KR, BRINKMEIER ML, KENNELL JA, et al: Identifcation of members of the Wnt signaling pathway in the embryonic pituitary gland. Mamm Genome 12: 843-851, 2001.
5. BRINKMEIER ML, POTOK MA, CHA KB, et al: TCF and Groucho-related genes infuence pituitary growth and development. Mol Endocrinol 17: 2152-2161, 2003.
6. KIOUSSI C, BRIATA P, BAEK SH, et al: Identification of a Wnt/Dvl/beta-Catenin → Pitx2 pathway mediating cell-type-specifc proliferation during development. Cell 111: 673-685, 2002.
7. BRINKMEIER ML, POTOK MA, DAVIS SW and CAMPER SA: TCF4 defciency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev biol 311: 396-407, 2007.
8. ZENG YA and NUSSE R: Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 6: 568-577, 2010.
9. POLAKIS P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
10. REED KR, ATHINEOS D, MENIEL VS, et al: B-catenin defciency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proc Natl Acad Sci USA 105: 18919-18923, 2008.
11. NELSON WJ and NUSSE R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487, 2004.
12. WILLERT K and JONES KA: Wnt signaling: Is the party in the nucleus? Genes Dev 20: 1394-1404, 2006.
13. GASTON-MASSUET C, ANDONIADOU CL, SIGNORE M, et al: Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U SA 108: 11482-11487, 2011.
14. LI W, ZHANG Y, ZHANG M, HUANG G and ZHANG Q: Wnt4 is over-expressed in human pituitary adenomas and is associated with tumor invasion. J Clin Neurosci 21: 137-141, 2014.
15. BENJAMIN JM and NELSON WJ: Bench to bedside and back again: Molecular mechanisms of alpha-catenin function and roles in tumorigenesis. Semin Cancer biol 18: 53-64, 2008.
16. KALANI MY, CHESHIER SH, CORD BJ, et al: Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci USA 105: 16970-16975, 2008.
17. NUSSE R: Wnt signaling and stem Cell control. Cell Res 18: 523-527, 2008.
18. LOGAN CY and NUSSE R: The Wnt signaling pathway in development and disease. Annu RevCell Dev biol 20: 781-810, 2004.
19. CADIGAN KM and PEIFER M: Wnt signaling from development to disease: Insights from model systems. Cold Spring Harb Perspect biol 1: A002881, 2009.
20. PARK GB, KIM DJ, KIM YS, LEE HK, KIM CW and HUR DY: Silencing of galectin-3 represses osteosarcoma Cell migration and invasion through inhibition of FAK/Src/Lyn activation and beta-catenin expression and increases susceptibility to chemo-therapeutic agents. Int J Oncol 46: 185-194, 2015.
21. BAI XL, ZHANG Q, YE LY, et al: Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/beta-catenin signaling. Oncogene: Oct 20, 2014 (Epub ahead of print).
22. SALAROLI R, RONCHI A, BUTTARELLI FR, et al: Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblas-toma. J Neurooncol: Sep 28, 2014 (Epub ahead of print).
23. GAO ZH, LU C, WANG MX, HAN Y and GUO LJ: Differential beta-catenin expression levels are associated with morphological features and prognosis of colorectal cancer. Oncol Lett 8: 2069-2076, 2014.
24. SAREDDY GR, PANIGRAHI M, CHALLA S, MAHADEVAN A and BABU PP: Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 55: 307-317, 2009.
25. TROVATO M, TORRE ML, RAGONESE M, et al: HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: An immunohistochemical characterization in view of targeted therapies. Endocrine 44: 735-743, 2013.
26. MA PC, TRETIAKOVA MS, NALLASURA V, JAGADEESWARAN R, HUSAIN AN and SALGIA R: Downstream signalling and specifc inhibition of c-MET/HGF pathway in small Cell lung cancer: Implications for tumour invasion. br J Cancer 97: 368-377, 2007.
27. LIOTTA LA and KOHN EC: The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
28. COUSSENS LM and WERB Z: Infammation and cancer. Nature 420: 860-867, 2002.
29. DE AGUIAR PH, AIRES R, LAWS ER, et al: Labeling index in pituitary adenomas evaluated by means of MIb-1: Is there a prognostic role? A critical review. Neurol Res 32: 1060-1071, 2010.
30. CULLY M, YOU H, LEVINE AJ and MAK TW: Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184-192, 2006.
31. FU Y, ZHANG Q, KANG C, et al: Inhibitory effects of adenovirus mediated COx-2, Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Int J Oncol 35: 583-591, 2009.
32. YUE X, LAN F, YANG W, et al: Interruption of beta-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. brain Res 1366: 27-37, 2010.
33. DECHOW TN, PEDRANZINI L, LEITCH A, et al: Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc Natl Acad Sci USA 101: 10602-10607, 2004.
34. SILVER DL, NAORA H, LIU J, CHENG W and MONTELL DJ: Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian Cancer Cell motility. Cancer Res 64: 3550-3558, 2004.
35. SENFT C, PRIESTER M, POLACIN M, et al: Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101: 393-403, 2011.
36. WANG J, LI X, LU X and PI L: The regulation of stat3 signal trans-duction pathway to G1 to S phase of laryngocarcinoma cell. Lin Chung Er bi Yan Hou Tou Jing Wai Ke Za Zhi 22: 699-703, 2008 (In Chinese).
37. LIU W, KUNISHIO K, MATSUMOTO Y, OKADA M and NAGAO S: Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas. J Clin Neurosci 12: 791-794, 2005.
38. GONG J, ZHAO Y, ABDEL-FATTAH R, et al: Matrix metallopro-teinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary 11: 37-48, 2008.